Form 4 for IT Gartner
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001127602-23-029857 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-18 | 2023-12-14 | IT | Kranich Robin B | EVP, CHRO | D - Sale to Iss | $454.01 | -1,230 | 15.9K | -7% | -$558.4K |
| D | 2023-12-18 | 2023-12-14 | IT | Kranich Robin B | EVP, CHRO | F - Tax | $454.01 | -1,230 | 14.7K | -8% | -$558.4K |
| D | 2023-12-18 | 2023-12-15 | IT | Kranich Robin B | EVP, CHRO | S - Sale+OE | $455.29 | -1,444 | 13.2K | -10% | -$657.4K |
| D | 2023-12-18 | 2023-12-14 | IT | Kranich Robin B | EVP, CHRO | M - OptEx | $143.01 | +3,904 | 17.1K | +29% | +$558.3K |
| D | 2023-12-18 | 2023-12-14 | IT | Kranich Robin B | EVP, CHRO | M - OptEx | $0.00 | -3,904 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-14 | D | D | 1,230 | $454.01 | 15,918 | D | — | — | (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| 2 | Common | Common Stock | 2023-12-14 | F | D | 1,230 | $454.01 | 14,688 | D | — | — | (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| 3 | Common | Common Stock | 2023-12-15 | S | D | 1,444 | $455.29 | 13,244 | D | — | — | |
| 4 | Common | Common Stock | 2023-12-14 | M | A | 3,904 | $143.01 | 17,148 | D | — | — | (F1) Represents shares acquired upon exercise of SARs. |
| 5 | Derivative | Stock Appreciation Rights | 2023-12-14 | M | D | 3,904 | $0.00 | 0 | D | $143.01 · 2020-02-06 to 2026-02-06 | 3,904 Common Stock | (F4) These SARS are part of an award that became exercisable in four substantially equal annual installations, commencing on February 6, 2020 and are fully exercisable. |